Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Experimental Hematology & Oncology|February 26, 2026
In vivo CAR-T engineering: insights from the 2025 ASH annual meetingGelayol Asadi, Misagh Rajabinejad
European Journal of Pharmacology|May 27, 2020
Immune semaphorins: Crucial regulatory signals and novel therapeutic targets in asthma and allergic diseasesRasoul Nasiri Kalmarzi, Misagh Rajabinejad, Ramin Lotfi
Inflammopharmacology|February 21, 2022
Immune-related adverse events (irAEs) in ankylosing spondylitis (AS) patients treated with interleukin (IL)-17 inhibitors: a systematic review and meta-analysisHossein Azadeh, Reza Alizadeh-Navaei, Alireza Rezaiemanesh, et al.
BMC Immunology|November 14, 2025
The effect of disrupted sleep on macrophage polarization: a systematic review and meta-analysis of animal studiesMonireh Askarzadeh, Rezvan Yazdian-Robati, Misagh Rajabinejad, et al.
Artificial Cells, Nanomedicine, and Biotechnology|November 9, 2019
The role of myeloid-derived suppressor cells in the pathogenesis of rheumatoid arthritis; anti- or pro-inflammatory cells?Misagh Rajabinejad, Farhad Salari, Ali Gorgin Karaji, et al.
International Immunopharmacology|August 5, 2021
Advanced glycation end products (AGEs) and its receptor, RAGE, modulate age-dependent COVID-19 morbidity and mortality. A review and hypothesisDurai Sellegounder, Parisa Zafari, Misagh Rajabinejad, et al.
Inflammation|October 17, 2022
Dimethyl Fumarate Inhibits Fibroblast Like Synoviocytes-mediated Inflammation and Joint Destruction in Rheumatoid ArthritisParisa Zafari, Mahdi Taghadosi, Fatemeh Faramarzi, et al.
International Immunopharmacology|March 23, 2021
The role of immune semaphorins in the pathogenesis of multiple sclerosis: Potential therapeutic targetsRamin Lotfi, Rasoul Nasiri Kalmarzi, Misagh Rajabinejad, et al.
Pathology, Research and Practice|July 19, 2025
AS1411 aptamer in melanoma therapy: Harnessing targeted strategies for precision treatmentMonireh Askarzadeh, Misagh Rajabinejad, Alireza Rafiei, et al.
Journal of Cellular Physiology|December 3, 2019
Regulatory T cells for amyotrophic lateral sclerosis/motor neuron disease: A clinical and preclinical systematic reviewMisagh Rajabinejad, Sedigheh Ranjbar, Leila Afshar Hezarkhani, et al.
Pageof 2